Literature DB >> 14688159

Familial clustering of impaired spermatogenesis: no evidence for a common genetic inheritance pattern.

Judith Gianotten1, G Henrike Westerveld, Nico J Leschot, Michael W T Tanck, Richard J Lilford, M Paola Lombardi, Fulco van der Veen.   

Abstract

BACKGROUND: The aetiology of impaired spermatogenesis is unknown in the majority of cases. Evidence of a contribution of genetic factors is still scarce. Therefore, the aim of our study was to assess whether male factor subfertility due to impaired spermatogenesis has a familial component and to test different genetic models of inheritance.
METHODS: Cases were all men with severe idiopathic impaired spermatogenesis attending our fertility clinic from January 1998 until December 2001. Controls were all men with normozoospermia attending our fertility clinic in the same period. Family data were collected from the medical records and by additional interviews of the probands. If subfertility of a first-degree relative was mentioned, permission was sought to contact the affected family member in order to obtain all medical information available, including the results of semen analyses.
RESULTS: In total, 160 patients and 285 controls were included in the analysis. Family size and number of brothers and sisters were equally distributed in both groups. In the patient group, 1.63% of the brothers who had tried to father a child were mentioned to be subfertile compared to 5.8% in the control group [odds ratio 3.18 (95% confidence interval 1.59-6.37)]. The subfertility among the brothers in the patient group was more often due to reduced semen parameters compared to the control group. The data did not fit with frequent autosomal dominant or recessive segregation.
CONCLUSION: Male factor subfertility due to impaired spermatogenesis appears to cluster in families. Our data suggests that heritable genetic factors play a role in a limited number of cases. Impaired spermatogenesis is not caused by a common genetic defect, but is most likely a complex disease in which several different factors play a role.

Entities:  

Mesh:

Year:  2004        PMID: 14688159     DOI: 10.1093/humrep/deh008

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1.

Authors:  Anu Bashamboo; Bruno Ferraz-de-Souza; Diana Lourenço; Lin Lin; Neil J Sebire; Debbie Montjean; Joelle Bignon-Topalovic; Jacqueline Mandelbaum; Jean-Pierre Siffroi; Sophie Christin-Maitre; Uppala Radhakrishna; Hassan Rouba; Celia Ravel; Jacob Seeler; John C Achermann; Ken McElreavey
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

2.  The male sterility and histoincompatibility (mshi) mutation in mice is a natural variant of microtubule-associated protein 7 (Mtap7).

Authors:  D R Magnan; D V Spacek; N Ye; Y-C Lu; T R King
Journal:  Mol Genet Metab       Date:  2009-03-05       Impact factor: 4.797

3.  Identification of potentially damaging amino acid substitutions leading to human male infertility.

Authors:  Anastasia Kuzmin; Keith Jarvi; Kirk Lo; Leia Spencer; Gary Y C Chow; Graham Macleod; Qianwei Wang; Susannah Varmuza
Journal:  Biol Reprod       Date:  2009-04-15       Impact factor: 4.285

4.  A familial study of azoospermic men identifies three novel causative mutations in three new human azoospermia genes.

Authors:  Moran Gershoni; Ron Hauser; Leah Yogev; Ofer Lehavi; Foad Azem; Haim Yavetz; Shmuel Pietrokovski; Sandra E Kleiman
Journal:  Genet Med       Date:  2017-02-16       Impact factor: 8.822

Review 5.  Disorders of spermatogenesis: Perspectives for novel genetic diagnostics after 20 years of unchanged routine.

Authors:  Frank Tüttelmann; Christian Ruckert; Albrecht Röpke
Journal:  Med Genet       Date:  2018-02-26

Review 6.  A comprehensive review of genetics and genetic testing in azoospermia.

Authors:  Alaa J Hamada; Sandro C Esteves; Ashok Agarwal
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.